PACE: A pivotal phase II trial of ponatinib in patients with CML and Ph+ALL resistant or intolerant to dasatinib or nilotinib, or with the T315I mutation.
Jorge E. Cortes
Consultant or Advisory Role - ARIAD (U); Bristol-Myers Squibb (U); ChemGenex (U); Novartis (U); Pfizer (U)
Research Funding - ARIAD; Bristol-Myers Squibb; ChemGenex; Deciphera; Novartis; Pfizer
Dong-Wook Kim
Consultant or Advisory Role - Bristol-Myers Squibb (U); IL-Yang Pharm; Novartis (U); Pfizer (U)
Honoraria - Bristol-Myers Squibb; Novartis
Research Funding - Bristol-Myers Squibb; Novartis
Javier Pinilla-Ibarz
Consultant or Advisory Role - ARIAD (U); Bristol-Myers Squibb (U); Novartis (U)
Honoraria - Bristol-Myers Squibb; Novartis
Research Funding - ARIAD; Bristol-Myers Squibb; Novartis
Ronald Paquette
No relevant relationships to disclose
Philipp D. le Coutre
Research Funding - Novartis
Charles Chuah
Honoraria - Bristol-Myers Squibb; Novartis
Franck E. Nicolini
Consultant or Advisory Role - Novartis (U)
Honoraria - ARIAD; Novartis
Research Funding - Novartis
Jane Apperley
Consultant or Advisory Role - ARIAD (U); Bristol-Myers Squibb (U); Novartis (U)
Honoraria - Bristol-Myers Squibb; Novartis
Research Funding - Novartis
Hanna Jean Khoury
No relevant relationships to disclose
Moshe Talpaz
Consultant or Advisory Role - ARIAD (U)
John F DiPersio
No relevant relationships to disclose
Daniel J DeAngelo
No relevant relationships to disclose
Delphine Rea
No relevant relationships to disclose
Elisabetta Abruzzese
No relevant relationships to disclose
Martin C Müller
Consultant or Advisory Role - Bristol-Myers Squibb (U); Novartis (U)
Honoraria - Bristol-Myers Squibb; Novartis
Research Funding - Novartis
Michele Baccarani
Consultant or Advisory Role - ARIAD (U); Bristol-Myers Squibb (U); Novartis (U); Pfizer (U)
Honoraria - ARIAD; Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - Novartis
Carlo Gambacorti-Passerini
Consultant or Advisory Role - Bristol-Myers Squibb (U); Novartis (U); Pfizer (U)
Honoraria - Bristol-Myers Squibb; Novartis; Pfizer
Research Funding - Pfizer
Christopher D. Turner
Employment or Leadership Position - ARIAD
Stock Ownership - ARIAD
Frank G. Haluska
Employment or Leadership Position - ARIAD
Stock Ownership - ARIAD (I)
Hagop Kantarjian
Consultant or Advisory Role - ARIAD (U)